SCHEDULE: Wasatch Advisors LP Discloses 13.3% Stake in Journey Medical Corp

Wasatch Advisors LP has reported beneficial ownership of 2,858,930 shares, representing 13.3% of the class, in Journey Medical Corp as of June 30, 2026.

Summary

• Wasatch Advisors LP has filed a Schedule 13G, indicating a significant ownership stake in Journey Medical Corp.
• The filing, dated July 15, 2026, covers the period ending June 30, 2026.
• Wasatch Advisors LP beneficially owns 2,858,930 shares of Journey Medical Corp's common stock.
• This ownership represents 13.3% of the total class of securities.
• The reporting person has sole voting power over 2,664,647 shares and sole dispositive power over 2,858,930 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, indicating a significant institutional investor's stake without providing operational or financial performance details.

Positives

• Wasatch Advisors LP's substantial ownership indicates strong conviction in Journey Medical Corp's prospects.
• The 13.3% stake suggests a significant institutional investor is closely aligned with the company's performance.

Future Outlook

The filing does not contain forward-looking statements or guidance. It is a disclosure of current ownership.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that significant Schedule 13G filings by investment managers like Wasatch Advisors LP often signal a belief in the target company's growth potential or undervaluation within its sector.

Stakeholder Impact

• Shareholders may view the increased stake by Wasatch Advisors LP as a positive signal of institutional confidence.
• The filing does not directly impact employees, customers, suppliers, or creditors at this time.

Key Dates

Keywords

Journey Medical Corp, Wasatch Advisors LP, Schedule 13G, Beneficial Ownership, SEC Filing, Investment, Common Stock, Institutional Investor